Thought leaders to provide in-depth insight on emerging treatments
and research
CRANBURY, N.J.–(BUSINESS WIRE)– OncLive®, a leading digital provider of
resources and information for oncology professionals, will present the
latest State of the Science Summit™: Treatment Options in Ovarian
Cancer, at the W New York (541 Lexington Ave New York, NY) on Sept. 14
from 5:30 to 9 p.m. The program will be chaired by Douglas A. Levine,
M.D., FACOG, FACS, professor, Department of Obstetrics and
Gynecology, director, Division of Gynecologic Oncology, NYU Langone
Laura and Isaac Perlmutter Cancer Center; and Peter R. Dottino, M.D., associate
professor of obstetrics, gynecology and reproductive science, Mount
Sinai Health System.
This conference will examine some of the most significant and
thought-provoking topics including genetic testing for ovarian cancer
families, early detection of fallopian tube cancer, robotic surgery,
immunotherapy and neoadjuvant chemotherapy. The topic presentations will
be followed by a robust panel discussion featuring the following experts:
-
Paul Sabbatini, M.D., internist and medical oncologist, deputy
physician-in-chief for clinical research, Memorial Sloan Kettering
Cancer Center -
John Martignetti, M.D., Ph.D., professor, genetics and genomic
sciences, oncologic sciences, obstetrics, gynecology and reproductive
science and pediatrics, Mount Sinai Health System -
Bhavana Pothuri, M.D., associate professor, Department of
Obstetrics and Gynecology, Perlmutter Cancer Center at NYU Langone -
Dmitriy Zamarin, M.D., Ph.D., medical oncologist, Memorial
Sloan Kettering Cancer Center -
Ophira M. Ginsburg, M.D., member of the faculty, Department of
Population Health; member of the faculty, Department of Medicine;
director, Perlmutter Cancer Center High Risk Program at NYU Langone -
Mario Leitao Jr., M.D., FACOG, FACS, fellowship director,
gynecology service; director, Minimal Access and Robotic Surgery
Program, Department of Surgery, Memorial Sloan Kettering Cancer Center
State of the Science Summit™ is a premier conference series hosted by
OncLive® with medical experts from across the nation. Aiming to discuss
current treatment options, these summits integrate academic and
community-based physicians and health care professionals across key
disciplines, including medical and surgical oncology and hematology.
Registration is free and open to all health care professionals and food
and drinks will be served. For more information and to register, visit www.onclive.com/meetings/soss or
contact Allison Cooper at ACooper@curetoday.com.
About OncLive®
A digital platform of resources for practicing oncologists, OncLive.com
offers oncology professionals information they can use to help provide
the best patient care. OncLive® is the official website for
Michael J. Hennessy Associates’ Oncology Specialty Group, which
publishes OncologyLive®, Oncology Nursing
News®, Oncology Business Management™ and
more. Michael J. Hennessy Associates Inc. is a full-service health care
communications company offering education, research and medical media,
including curetoday.com and CURE® magazine, the
largest U.S. consumer publication focused entirely on cancer. Combining
science and humanity to make cancer understandable, CURE® reaches
patients, cancer centers and advocacy groups.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170829005185/en/
Contacts
OncLive® Media:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi
Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com
Source: OncLive
Cet article OncLive® Presents State of the Science Summit™: Treatment Options in
Ovarian Cancer est apparu en premier sur EEI-BIOTECHFINANCES.